Skip to main content
Figure 4 | BMC Infectious Diseases

Figure 4

From: QuantiFERON-TB gold in-tube implementation for latent tuberculosis diagnosis in a public health clinic: a cost-effectiveness analysis

Figure 4

Results from a Probabalistic Sensitivity-Analysis using Monte Carlo Simulation Methods. A) Cost-effectiveness acceptability curve showing probability that the intervention will be cost-effective compared to treating all TST-positive referrals at varying willingness-to-pay thresholds. B) Incremental cost-effectiveness of QFT-GIT vs. Standard Algorithm during iterations of Monte Carlo Simulation. Ellipse represents 95% confidence points. Diagonal dashed line represents ICERs at a WTP threshold of $50,000. Points to the right of this dashed line are considered cost-effective. Dotted horizontal line shows incremental cost of $0.

Back to article page